Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Zhang, Wei ^a   Wang, Lin ^b   Zheng, Fang ^a   Zou, Ruhai ^b   Xie, Changqing ^c   Guo, Qiannan ^a   Hu, Qian ^a   Chen, Jianing ^a   Yang, Xing ^a   Yao, Herui ^a   Song, Erwei ^a   Xiang, Yanqun ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; GENETIC MARKER; TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIMARY TUMOR; CHINA; EPIDEMIOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MORTALITY; NASOPHARYNX TUMOR; NUCLEOTIDE SEQUENCE; PREVALENCE; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SECONDARY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

BASE SEQUENCE; BIOMARKERS, TUMOR; CHINA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RNA, LONG NONCODING; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 84942770736     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/618924     Document Type: Article

References (61)

1. K. Shanmugaratnam, "Nasopharyngeal carcinoma: epidemiology, histopathology and aetiology, " Annals of the Academy of Medicine Singapore, vol. 9, no. 3, pp. 289-295, 1980.
2. M. C. Yu and J.-M. Yuan, "Epidemiology of nasopharyngeal carcinoma, " Seminars in Cancer Biology, vol. 12, no. 6, pp. 421-429, 2002.
3. S.-H. Ou, J. A. Zell, A. Ziogas, and H. Anton-Culver, "Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology, " Annals of Oncology, vol. 18, no. 1, pp. 29-35, 2007.
4. Y. S. Zong, R. F. Zhang, S. Y. He, and H. Qiu, "Histopathologic types and incidence of malignant nasopharyngeal tumors in Zhongshan county, " Chinese Medical Journal, vol. 96, no. 7, pp. 511-516, 1983.
5. T. L. Vaughan, J. A. Shapiro, R. D. Burt et al., "Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type, " Cancer Epidemiology Biomarkers & Prevention, vol. 5, no. 8, pp. 587-593, 1996.
6. A. Mutirangura, W. Pornthanakasem, A. Theamboonlers et al., "Epstein-Barr viralDNA in serumof patients with nasopharyngeal carcinoma, " Clinical Cancer Research, vol. 4, no. 3, pp. 665-669, 1998.
7. J.-C. Lin, K. Y. Chen, W.-Y. Wang et al., "Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival, " Journal of Clinical Oncology, vol. 19, no. 10, pp. 2607-2615, 2001.
8. J. C. Lin, W.Y.Wang, K. Y. Chen et al., "Quantificationof plasma Epstein-Barr virusDNAin patients with advanced nasopharyngeal carcinoma, "The New England Journal ofMedicine, vol. 350, pp. 2461-2470, 2004.
9. E.-L. Tan, S.-C. Peh, and C.-K. Sam, "Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections, " Journal of Medical Virology, vol. 69, no. 2, pp. 251-257, 2003.
10. W.-H. Jia, X.-Y.Luo, B.-J. Feng et al., "Traditional Cantonesediet and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China, " BMC Cancer, vol. 10, article 446, 2010.
11. E. E. Vokes, D. N. Liebowitz, and R. R. Weichselbaum, "Nasopharyngeal carcinoma, " The Lancet, vol. 350, no. 9084, pp. 1087-1091, 1997.
12. J. Polesel, S. Franceschi, R. Talamini et al., "Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population, " Oral Oncology, vol. 47, no. 6, pp. 541-545, 2011.
13. A. W. M. Lee, Y. F. Poon, W. Foo et al., "Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure, " International Journal of Radiation Oncology Biology Physics, vol. 23, no. 2, pp. 261-270, 1992.
14. J. S.Mattick, "The genetic signatures of noncoding RNAs, " PLoS Genetics, vol. 5, Article IDe1000459, 2009.
15. K. V. Prasanth and D. L. Spector, "Eukaryotic regulatory RNAs: an answer to the "genome complexity" conundrum, " Genes & Development, vol. 21, no. 1, pp. 11-42, 2007.
16. J. S. Mattick and I. V. Makunin, "Non-coding RNA, " Human Molecular Genetics, vol. 15, pp. R17-R29, 2006.
17. M. Chaudhary, S. Gupta, S. Khare, and S. Lal, "Diagnosis of tuberculosis in an era of HIV pandemic: a review of current status and future prospects, " Indian Journal of Medical Microbiology, vol. 28, no. 4, pp. 281-289, 2010.
18. A. Gabory, M.-A. Ripoche, T. Yoshimizu, and L. Dandolo, "The H19 gene: regulation and function of a non-coding RNA, " Cytogenetic and Genome Research, vol. 113, no. 1-4, pp. 188-193, 2006.
19. S. Lottin, E. Adriaenssens, T. Dupressoir et al., "Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells, " Carcinogenesis, vol. 23, no. 11, pp. 1885-1895, 2002.
20. J. E.Wilusz, H. Sunwoo, and D. L. Spector, "Long noncoding RNAs: functional surprises from the RNA world, " Genes & Development, vol. 23, no. 13, pp. 1494-1504, 2009.
21. P. P. Amaral and J. S. Mattick, "Noncoding RNA in development, " Mammalian Genome, vol. 19, no. 7-8, pp. 454-492, 2008.
22. M. E. Dinger, P. P. Amaral, T. R. Mercer, and J. S. Mattick, "Pervasive transcription of the eukaryotic genome: functional indices and conceptual implications, " Briefings in Functional Genomics and Proteomics, vol. 8, no. 6, Article ID elp038, pp. 407-423, 2009.
23. M. Guttman, I. Amit, M. Garber et al., "Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals, " Nature, vol. 458, no. 7235, pp. 223-227, 2009.
24. T. R.Mercer, M. E. Dinger, and J. S. Mattick, "Long non-coding RNAs: insights into functions, " Nature Reviews Genetics, vol. 10, no. 3, pp. 155-159, 2009.
25. J.Zhao, B. K. Sun, J.A.Erwin, J.-J. Song, and J. T. Lee, "Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome, " Science, vol. 322, no. 5902, pp. 750-756, 2008.
26. O. Wapinski and H. Y. Chang, "Long noncoding RNAs and human disease, " Trends in Cell Biology, vol. 21, no. 6, pp. 354-361, 2011.
27. M. Huarte and J. L. Rinn, "Large non-coding RNAs: missing links in cancer?" Human Molecular Genetics, vol. 19, no. 2, pp. R152-R161, 2010.
28. K. L.Yap, S. Li, A.M.Muñoz-Cabello et al., "Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a, " Molecular Cell, vol. 38, no. 5, pp. 662-674, 2010.
29. Y. Nie, X. Liu, S. Qu, E. Song, H. Zou, and C. Gong, "Long noncoding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival, " Cancer Science, vol. 104, no. 4, pp. 458-464, 2013.
30. V. Tripathi, J. D. Ellis, Z. Shen et al., "The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation, "Molecular Cell, vol. 39, no. 6, pp. 925-938, 2010.
31. T. Hung, Y. Wang, M. F. Lin et al., "Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters, " Nature Genetics, vol. 43, no. 7, pp. 621-629, 2011.
32. A. Ng, J. P. Tang, C. H. K. Goh, and K. M. Hui, "Regulation of the H19 imprinting gene expression in human nasopharyngeal carcinoma bymethylation, " International Journal of Cancer, vol. 104, no. 2, pp. 179-187, 2003.
33. W. Zhang, C. Huang, Z. Gong et al., "Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph nodemetastasis in nasopharyngeal carcinoma, " Journal of Molecular Histology, vol. 44, pp. 545-554, 2013.
34. W. Gao, J. Y. Chan, and T.-S. Wong, "Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma, " BioMed Research International, vol. 2014, Article ID 404567, 9 pages, 2014.
35. E. A. Gibb, C. J. Brown, and W. L. Lam, "The functional role of long non-coding RNA in human carcinomas, " Molecular Cancer, vol. 10, article 38, 2011.
36. J. L. Rinn, M.Kertesz, J. K.Wang et al., "Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs, " Cell, vol. 129, no. 7, pp. 1311-1323, 2007.
37. U. A. Ørom, T. Derrien, M. Beringer et al., "Long noncoding RNAs with enhancer-like function in human cells, " Cell, vol. 143, no. 1, pp. 46-58, 2010.
38. A. M. Khalil, M. Guttman, M. Huarte et al., "Many human large intergenic noncoding RNAs associate with chromatinmodifying complexes and affect gene expression, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 28, pp. 11667-11672, 2009.
39. T. Chiyomaru, S. Yamamura, S. Fukuhara et al., "Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenicHOTAIR, " PLoS ONE, vol. 8, Article IDe70372, 2013.
40. J. Chou, Y.-C. Lin, J. Kim et al., "Nasopharyngeal carcinoma - review of the molecular mechanisms of tumorigenesis, " Head and Neck, vol. 30, no. 7, pp. 946-963, 2008.
41. K. Panzitt, M. M. O. Tschernatsch, C. Guelly et al., "Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA, " Gastroenterology, vol. 132, no. 1, pp. 330-342, 2007.
42. X. Zhang, Y. Zhou, K. R. Mehta et al., "A pituitary-derived MEG3 isoformfunctions as a growth suppressor in tumor cells, " Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 11, pp. 5119-5126, 2003.
43. W. Yu, D. Gius, P. Onyango et al., "Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA, " Nature, vol. 451, no. 7175, pp. 202-206, 2008.
44. N. Popov and J. Gil, "Epigenetic regulation of the INK4B-ARFINK4a locus: in sickness and in health, " Epigenetics, vol. 5, no. 8, pp. 685-690, 2010.
45. K.-C. Huang, P. H. Rao, C. C. Lau et al., "Relationship of XIST expression and responses of ovarian cancer to chemotherapy, " Molecular CancerTherapeutics, vol. 1, no. 10, pp. 769-776, 2002.
46. S. M. Sirchia, S. Tabano, L. Monti et al., "Misbehaviour of XIST RNA in breast cancer cells, " PLoS ONE, vol. 4, Article IDe5559, 2009.
47. P. Ji, S. Diederichs, W.Wang et al., "MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer, " Oncogene, vol. 22, no. 39, pp. 8031-8041, 2003.
48. A. Guffanti, M. Iacono, P. Pelucchi et al., "A transcriptional sketch of a primary human breast cancer by 454 deep sequencing, " BMC Genomics, vol. 10, article 163, 2009.
49. K. Yamada, J. Kano, H. Tsunoda et al., "Phenotypic characterization of endometrial stromal sarcoma of the uterus, " Cancer Science, vol. 97, no. 2, pp. 106-112, 2006.
50. R. Lin, S. Maeda, C. Liu, M. Karin, and T. S. Edgington, "A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas, " Oncogene, vol. 26, no. 6, pp. 851-858, 2007.
51. J.-H. Luo, B. Ren, S. Keryanov et al., "Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas, " Hepatology, vol. 44, no. 4, pp. 1012-1024, 2006.
52. J. Lu, G. Getz, E. A.Miska et al., "MicroRNA expression profiles classify human cancers, " Nature, vol. 435, no. 7043, pp. 834-838, 2005.
53. S.-L. Yu, H.-Y. Chen, G.-C. Chang et al., "MicroRNA signature predicts survival and relapse in lung cancer, " Cancer Cell, vol. 13, no. 1, pp. 48-57, 2008.
54. C. J.Woo and R. E. Kingston, "HOTAIR lifts noncoding RNAs to new levels, " Cell, vol. 129, no. 7, pp. 1257-1259, 2007.
55. K. Kim, I. Jutooru, G. Chadalapaka et al., "HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer, " Oncogene, vol. 32, no. 13, pp. 1616-1625, 2013.
56. X.-B. Lv, G.-Y. Lian, H.-R. Wang, E. Song, H. Yao, and M.-H. Wang, "Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival, " PLoS ONE, vol. 8, Article IDe63516, 2013.
57. O. Lustig, I. Ariel, J. Ilan, E. Lev-Lehman, N. de-Groot, and A. Hochberg, "Expression of the imprinted geneH19 in the human fetus, " Molecular Reproduction and Development, vol. 38, no. 3, pp. 239-246, 1994.
58. I. Ariel, N. de Groot, and A. Hochberg, "Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection, " The American Journal of Medical Genetics, vol. 91, pp. 46-50, 2000.
59. K. Hashimoto, C. Azuma, Y. Tokugawa et al., "Loss of H19 imprinting and up-regulation of H19 and SNRPN in a case with malignant mixed müllerian tumor of the uterus, " Human Pathology, vol. 28, no. 7, pp. 862-865, 1997.
60. K.Hibi, H. Nakamura, A.Hirai et al., "Loss of H19 imprinting in esophageal cancer, " Cancer Research, vol. 56, no. 3, pp. 480-482, 1996.
61. Y. Fellig, I. Ariel, P. Ohana et al., "H19 expression in hepatic metastases from a range of human carcinomas, " Journal of Clinical Pathology, vol. 58, no. 10, pp. 1064-1068, 2005.